24 results
8-K
EX-99.1
OVID
Ovid Therapeutics Inc
8 Mar 24
Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results
8:20am
for its current pipeline programs and clinical results for soticlestat from Takeda in 2024.
◦To manage its capital resources, the Company leadership has
8-K
EX-99.1
OVID
Ovid Therapeutics Inc
4 Aug 23
Ovid Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Updates
9:10am
with Graviton Bioscience to develop highly selective ROCK2 inhibitors for rare neurological conditions
Expanded scientific leadership team … -related disorders and other brain diseases. Our experienced team, under the leadership of Drs. Zhong Zhong and Manoj Malhotra, as our respective
8-K
EX-99.1
OVID
Ovid Therapeutics Inc
5 May 23
Ovid Therapeutics Reports First Quarter 2023 Financial Results and Corporate Updates
8:16am
and leadership team to steward the business and its programs.
Pipeline Update
GV101 and selective ROCK2 inhibitor library: In May 2023, Ovid entered
8-K
EX-99.1
v2ek1kwe
16 Aug 21
Ovid Therapeutics Reports Second Quarter 2021 Financial Results
8:06am
8-K
EX-99.1
qpzfzsp 3qbacza82hk
23 Jun 21
Regulation FD Disclosure
8:05am
8-K
EX-99.1
0hgl3 ghqfyr
18 May 21
Regulation FD Disclosure
3:11pm
8-K
EX-99.1
sfga2jl7ndrhst
13 May 21
Ovid Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
4:44pm
8-K
EX-99.1
enoph6lcf0oz66k2s cf
19 Apr 21
Regulation FD Disclosure
4:22pm
8-K
EX-99.1
0dz42lxmp
9 Apr 21
Regulation FD Disclosure
10:01am
8-K
EX-99.1
hqu5eyl cg
13 Mar 20
Regulation FD Disclosure
9:06am
8-K
EX-99.1
rt7akk6b7oo2kzbkfpq
11 Mar 20
Ovid Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results, Provides Corporate Update for 2020
8:05am
8-K
EX-99.1
zsu05xikjegdjc9
2 Mar 20
Regulation FD Disclosure
3:48pm
8-K
EX-99.1
esi15r
7 Jan 20
Ovid Therapeutics Provides 2020 Update in Preparation for Multiple Clinical Data Readouts Across Rare Neurological Disease Platform
8:05am
8-K
EX-99.1
0qlq1o6znpyem8
1 Nov 19
Ovid Therapeutics Announces Senior Management Promotions in Preparation for Multiple Data Readouts Expected in 2020
8:23am